Steven Haas
Orthopaedic Surgery · New York, NYNPI 1952318107
Payments from drug & device makers
What this record shows
This record is dominated by royalties or licence payments: $10,182,797 of the $11,254,173 with a category attached, or 90.5%. Smith+Nephew accounts for 95.7% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2021 at $2,898,942 and has fallen 50.3% since, to $1,440,701 in 2025. Among orthopaedic surgery clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 731 payments — averaging $15,396 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$10.8M
- Orthalign Inc$437K
- Heraeus Medical, LLC.$38K
- Amgen$2K
- Medtronic$1K
- Johnson & Johnson$440
- plus $831 from 6 others
Across 37 payments — averaging $7816.46 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Smith+Nephew$289K
What the payments were for
- Royalty or licence$10,182,79790%
- Consulting fees$471,6094%
- Speaking & faculty fees$448,4864%
- Travel & lodging$127,2041%
- Food & beverage$23,8990%
- Education$1770%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 571 | $10,775,825 |
| Orthalign Inc | 36 | $436,507 |
| Heraeus Medical, LLC. | 6 | $37,876 |
| Amgen | 86 | $1,539 |
| Medtronic(2 entities) | 12 | $1,156 |
| Johnson & Johnson(2 entities) | 6 | $440 |
| Zimmer Biomet | 5 | $270 |
| Stryker | 2 | $150 |
| Dynasplint Systems Inc. | 4 | $148 |
| Janssen Scientific Affairs, LLC | 1 | $138 |
| KCI USA, Inc. | 1 | $108 |
| Illuminoss Medical, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Journey II$5,014,991
- Journey II BCS$4,183,912
- GENESIS II$1,201,091
- REAL INTELLIGENCE$723,591
- Legion$447,517
- ORTHALIGN PLUS$423,939
- JOURNEY$383,624
- VISIONAIRE$239,173
- Legion Revision$189,366
- NAVIO$153,642
- POLARSTEM$84,036
- R3 ACETABULAR$79,961
- OR3O Dual Mobility$75,639
- K-15 PORK$58,413
- Journey II XR$57,270
- Journey II CR$48,710
- Navio Surgical System$44,294
- Tandem$40,607
- PALACOS$37,837
- RI.HIP NAVIGATION$36,515
How this compares
$11,254,173 in reported general payments places this provider in the 95th percentile of 1,079 orthopaedic surgery providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone Hcl | 12 | $137 |
| Amoxicillin | 74 | $116 |
| Clindamycin Hcl | 13 | $81 |
| Meloxicam | 24 | $68 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in New York
- Anthony RomeoNew York$26.8M
- Lawrence LenkeNew York$26.8M
- Edwin SuNew York$13.2M
- William RicciNew York$11.6M
- Giles ScuderiNew York$10.7M
- Joseph ZuckermanNew York$9.9M
- Evan FlatowNew York$9.6M
- Bradford ParsonsNew York$9.4M
- Geoffrey WestrichNew York$7.1M
- Andrew PearleNew York$6.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.